Health ❯ Patient Care

Treatment Options

Medication Oral Medications Medications Symptom Management Innovative Therapies Insulin Therapy Surgery Cancer Treatment Supportive Care Gene Therapy

FDA Asks Drugmakers for More Data on Testosterone Use in Menopausal Women

This could open a pathway to female-specific approvals if trials resolve unanswered risks to heart and breast health.

Ultragenyx Phase 3 Angelman Drug Fails to Show Benefit

Stem-Cell Dopamine Grafts Found Feasible and Safe at One Year in Parkinson’s Trial

FDA Grants Accelerated Approval to Trutakna for IgA Nephropathy

World Multiple Sclerosis Day Highlights Need for Faster Diagnosis and Better Access in Brazil

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

AI Flags Pancreatic Cancer on CT Scans Years Before Diagnosis, Study Says

CDC Flags Rapid Rise of Extensively Drug-Resistant Shigella in U.S.

Miss North Carolina 2024 Carrie Everett Dies at 22 After Rare Gastric Cancer

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

Early-Onset Colorectal Cancer Surges, Prompting Fresh Calls for Screening at 45

Ahead of World Glaucoma Day, Experts Urge Annual Eye Exams and Reject Cannabis as Treatment

Polilaminina Enters Regulated Testing as Lead Researcher Moves to Correct Preprint

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Emma Willis Reveals Lifelong Heart Defect as She Backs BHF Awareness Drive

Study Ties NT‑proBNP Blood Test to Complication Risk in Hypertrophic Cardiomyopathy